Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Dengue Fever
Research from L. Lazo and colleagues has provided new data on dengue fever
May 13th, 2009
"A vaccine against dengue virus must be able to induce an effective and equivalent immune response to the four viral serotypes; however, some studies have revealed that DEN4 (dengue-virus serotype 4) induces a weaker immune response than the others in quadrivalent (tetravalent') formulations. We have previously reported the protective capacity, in a viral encephalitis murine model, of fusion protein P64k-envelope domain III of DEN1, DEN2 and DEN3," scientists writing in the journal Biotechnology and Applied Biochemistry report. "We also reported that the P64k protein can be used as a carrier in two different positions: the insertion following the first 45 amino...
Source: Vaccine Weekly (2009-05-13)
|
